{
 "drug": "Aspirin Suppository",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "07/23/2026",
 "dayN": 33,
 "cat": "Analgesia/Addiction",
 "companies": [
  "Padagis US LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "07/23/2026",
   "update_type": "New",
   "initial_posting_date": "07/23/2026",
   "package_ndc": "0574-7034-12",
   "generic_name": "Aspirin Suppository",
   "contact_info": "(800) 775-2054",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "brand_name": [
     "ASPIRIN"
    ],
    "generic_name": [
     "ASPIRIN"
    ],
    "manufacturer_name": [
     "Padagis US LLC"
    ],
    "product_ndc": [
     "0574-7034"
    ],
    "product_type": [
     "HUMAN OTC DRUG"
    ],
    "route": [
     "RECTAL"
    ],
    "substance_name": [
     "ASPIRIN"
    ],
    "rxcui": [
     "198464"
    ],
    "spl_id": [
     "a6ca751c-7438-4a0f-adae-d176f73f4915"
    ],
    "spl_set_id": [
     "cce244aa-cd79-49c8-b68e-267f2bd0ef67"
    ],
    "package_ndc": [
     "0574-7034-12"
    ],
    "nui": [
     "N0000000160",
     "N0000008836",
     "M0001335",
     "N0000175722",
     "N0000175578",
     "N0000008832"
    ],
    "pharm_class_moa": [
     "Cyclooxygenase Inhibitors [MoA]"
    ],
    "pharm_class_pe": [
     "Decreased Prostaglandin Production [PE]",
     "Decreased Platelet Aggregation [PE]"
    ],
    "pharm_class_cs": [
     "Anti-Inflammatory Agents, Non-Steroidal [CS]"
    ],
    "pharm_class_epc": [
     "Nonsteroidal Anti-inflammatory Drug [EPC]",
     "Platelet Aggregation Inhibitor [EPC]"
    ],
    "unii": [
     "R16CO5Y76E"
    ]
   },
   "update_date": "07/23/2026",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Cardiovascular"
   ],
   "dosage_form": "Suppository",
   "presentation": "Aspirin, Suppository, 300 mg (NDC 0574-7034-12)",
   "company_name": "Padagis US LLC",
   "status": "To Be Discontinued"
  }
 ]
}